NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Industry news » TOP 50 Pharmas  1  2  » 
found files: 23
Pfizer »24/05/2007 [Industry news]
Pfizer Says Research and Development Head John LaMattina Will Retire This Year

Pfizer said today that the President of Pfizer Global Research and Development, Dr. John LaMattina, who made many important contributions to the Company’s research division throughout his 30-year career, will retire from Pfizer by the end of this year. The company will begin a search both inside and outside the company for his successor, and Dr. LaMattina has agreed to remain during this period to ensure a smooth transition....   more»

Merck & Co »20/05/2007 [Industry news]
Merck Announces Resignation of Peter Loescher, President, Global Human Health

WHITEHOUSE STATION, N.J., May 20, 2007 - Merck & Co., Inc. today announced the resignation of Peter Loescher, president, Global Human Health. Effective July 1, 2007, Mr. Loescher, 49, will take on the position of president and chief executive officer at Siemens AG. "We thank Peter for his contributions to Merck and wish him and his family well in this new endeavor," said Richard T. Clark, chairman, president and chief executive officer. "Merck remains fully committed to the strategic initiatives and operating goals established for the Global Human Health (GHH) organization. We continue to be pleased with the strong business performance across all the GHH franchises and regions, and we are confident that it will continue." Mr. Loescher will remain for a period of time to help with the leadership transition. Merck expects to name a new leader for the GHH organization so...   more»

Novartis »08/08/2007 [Industry news]
MNCs may go to China for R&D

NEW DELHI: Multinational drug makers would prefer China for investments in pharmaceutical research so long as India keeps the bar for patenting a drug so high, warns drug major Novartis on Monday after the Madras High Court turned down the company\'s challenge to the country’s patent law....   more»

Sanofi-Aventis »02/11/2007 [Industry news]
Sanofi Pasteur wins Flu Vaccine contract for Beijing

In October Beijing released the 2007 tendering results for influenza vaccine, marking the first time the vaccine has been included in Beijing's reimbursement system. Sanofi Pasteur will supply 1.2 million doses of the influenza vaccine, an amount that should generate RMB 48 million for the company. Four domestic manufacturers, Sinovac, Jiangsu Yanshen, Zhejiang Tianyuan, and Dalian Yalifeng, will provide the remaining 1.6 million doses. Five additional manufacturers, Changchun Changsheng, Shanghai Institute of Biological Products, Berna, GSK, and Novartis, also took part in the bidding but were not selected to provide the drug. In September, Beijing announced that it would purchase 2.8 million doses of the influenza vaccine for approximately RMB 100 million to provide free flu vaccinations for Beijing citizens over 60 years of age and to subsidize vaccinations for schoolchildren. Vaccines from Sanofi Pasteur with a tendering price of RMB 40 will be used to vaccinate schoolchildren and charged at RMB 20. Vaccines from four domestic producers with a tendering price of RMB 34 will be provided free to Beijing's senior citizens. The influenza vaccine is a Class II vaccine in China and therefore is not covered by the national government reimbursement system....   more»

Merck & Co »27/01/2008 [Industry news]
Taiwan to get Merck Asia Technology Training Center

American pharma giant Merck has said it will base its Asia Technology Training Center in Taiwan. Merck said it was starting the center in Taiwan due to its strong support for pharma companies. Last July, Taiwan promulgated the statute for developing biotechnological new pharmaceuticals enterprises which helps pharma and biotechnology firms to have a strong research base in the island. Wu Shuh-min, chairman Development Center of Biotechnology said the new effort by Taiwan has improved its image as an ideal investment destination for pharmaceuticals and biotechnology. Wu also said the center will work with Merck to boost cooperation...   more»

Roche »07/02/2009 [Industry news]
Roche Seeks Biotech Licensing, Takeovers in China

Roche Holding AG, Switzerland’s biggest drugmaker, may make its first acquisition of a Chinese biotechnology company or buy rights to a compound developed in the country later this year....   more»

Johnson & Johnson »16/03/2009 [Industry news]
Shanghai may test baby bath products

Baby products from Johnson & Johnson may be tested by experts from the Shanghai food and drug administration after a report that they contain chemicals which could cause cancer....   more»

GlaxoSmithKline »11/06/2009 [Industry news]
GlaxoSmithKline collaborates on flu vaccine

(GSK) is to join forces with another drugs company in a deal which will see them unite to try and find a flu immunisation for the Chinese market....   more»

Bayer »13/07/2009 [Industry news]
Scigen signs insulin deal with Bayer in China

Singapore-based biotechnology company, SciGen and its Polish holding company, Bioton have signed an exclusive insulin supply and distribution agreement with Bayer Schering Pharma, in China....   more»

»17/07/2009 [Industry news]
Novartis AG to Offer Management BiMBA in China

In Beijing, Novartis has established a Sino-European Novartis University of China...   more»

Pfizer »19/08/2009 [Industry news]
Pfizer bids to recapture Viagra China brand name falls limp

The Supreme Peoples Court of China has rejected Pfizers appeal to turn over a previous ruling regarding Pfizer s brand name rights to its erectile dysfunction (ED) drug Viagra,...   more»

Roche »05/11/2009 [Industry news]
Roche Opens Singapore Manufacturing Facility for Projects Initiated by Genentech

Roche has opened a new $500 million biologics manufacturing facility in Singapore in the Tuas Biomedical Park....   more»

Pfizer »11/11/2009 [Industry news]
BMP Sunstone Partners with Pfizer to Distribute Endometriosis Treatment in China

BMP Sunstone Corporation and Pfizer China (NYSE: PFE) have formed a strategic partnership to distribute and promote Depo-Provera (Medroxy-progesterone Acetate), a Pfizer product used to treat endometriosis, in China....   more»

Bayer »16/11/2009 [Industry news]
Bayer to sell Vetericyn animal healthcare product in China, Taiwan

Oculus Innovative Sciences has announced that its development partners, Bayer Animal Health divisions in China and Taiwan, recently secured regulatory approvals in both those countries to develop and market Microcyn-based Vetericyn products for their respective animal healthcare markets....   more»

Roche »17/12/2009 [Industry news]
Roche lends helping hand to MOH to support organ transplant programs

Roche Pharmaceuticals is teaming up with the Ministry of Health (MOH) to launch the China Organ Transplant Development Program, according to Beijing Youth Daily December 16....   more»

Bayer »28/01/2010 [Industry news]
Chasing Exforge- Bayer Schering starts CCB/ARB antihypertensive trial in China

Bayer Schering announced January 26 that it has begun phase IV clinical trials of a new antihypertensive combination in the Asia Pacific region in which China will play an essential role,...   more»

Sanofi-Aventis »01/02/2010 [Industry news]
Sanofi, Minsheng in consumer healthcare deal

French drug giant Sanofi-aventis has signed an agreement with Minsheng Pharmaceutical of China to form a new consumer healthcare joint venture....   more»

»31/01/2010 [Industry news]
Glaxo Smith Kline set to slash 4,000 jobs

Pharmaceutical giant pushes into emerging markets as it squeezes costs in the West...   more»

Roche »11/02/2010 [Industry news]
CapitalBio Corporation Certified to Provide Roche NimbleGen, Inc Array Services in China

Roche NimbleGen announced today that Beijing-based genomic services provider CapitalBio has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program....   more»

Eli Lilly & Co »30/03/2010 [Industry news]
Eli Lilly to invest aggressively in China

Eli Lilly to launch 15 new products in China in 5 yrs...   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.